Research Overview
Exploring cutting-edge nanomedicine solutions for global health challenges.
Nanoparticles in Drug Delivery
Our goal is to utilize nanoparticles for controlled-release drug delivery. Using nanoparticles enables us to create formulations with trigger-responsive or extended drug release. This reduces the frequency of administration and helps maintain therapeutic drug levels in the bloodstream, minimizing side effects. Our research explores various types of nanoparticles - such as liposomes, polymeric nanoparticles, silica nanoparticles, gold nanoparticles, and micelles - and investigates how these systems enhance the solubility and stability of poorly soluble drugs.
Moreover, we are developing novel targeted drug delivery systems for specific tissues, improving the precision of chemotherapy by reducing off-target effects. We also work on enhancing the cellular uptake of drugs using nanoparticles that can penetrate cell membranes or biological barriers more efficiently. Through this approach, we aim to overcome challenges related to the formulation of insoluble drugs, enabling more effective treatments for a variety of diseases, such as cancer, infectious diseases, inflammatory diseases, etc.
Regenerative Medicine
The development of scaffolds as substitutes for damaged or diseased tissues are of great value. These scaffolds are designed to provide structural support for cell growth and promote tissue regeneration. By using materials such as biodegradable polymers, we aim to create scaffolds that not only support cell attachment but also release bioactive molecules (i.e., growth hormones) that encourage cell proliferation and differentiation.
One of the principal areas of our work involves 3D printing technology, which allows us to create scaffolds with highly precise geometries. This technology enables the design of scaffolds that can support complex tissue architectures, making regeneration of more functional tissues possible. Furthermore, we are investigating the use of drug-loaded scaffolds, which combine tissue engineering with localized drug delivery. These scaffolds can release therapeutic agents directly at the site of injury, accelerating the healing process and improving the outcomes of tissue repair.
Carriers for Gene Delivery
The development of scaffolds as substitutes for damaged or diseased tissues are of great value. These scaffolds are designed to provide structural support for cell growth and promote tissue regeneration. By using materials such as biodegradable polymers, we aim to create scaffolds that not only support cell attachment but also release bioactive molecules (i.e., growth hormones) that encourage cell proliferation and differentiation.
One of the principal areas of our work involves 3D printing technology, which allows us to create scaffolds with highly precise geometries. This technology enables the design of scaffolds that can support complex tissue architectures, making regeneration of more functional tissues possible. Furthermore, we are investigating the use of drug-loaded scaffolds, which combine tissue engineering with localized drug delivery. These scaffolds can release therapeutic agents directly at the site of injury, accelerating the healing process and improving the outcomes of tissue repair.